De Novo device
Cognoa ASD Diagnosis Aid
Cognoa, Inc. · Pediatric Autism Spectrum Disorder Diagnosis Aid (QPF, Class II) · First FDA decision Jun 2, 2021, newest Jun 2, 2021
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
1
Naming "Cognoa ASD"
MAUDE reports
0
Brand "Cognoa ASD", since 2015
PubMed studies
0
Mentioning "Cognoa ASD"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Cognoa ASD Diagnosis AidNew device typeBreakthroughDe Novo
DEN200069 · Decided Jun 2, 2021 · 211 days after receipt
Device type: Pediatric Autism Spectrum Disorder Diagnosis Aid (QPF) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cognoa ASD", any status and sponsor, newest update first.
Cognoa, Inc.Not on our public-company list
NCT04326231 · 10 participants · Start Mar 17, 2020 · Primary completion Jul 31, 2020
Device: Usability assessment of Cognoa ASD Therapeutic Device · For: Autism Spectrum Disorder
Sites: Palo Alto, California
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cognoa ASD", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QPF
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Cognoa ASD"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QPF.
- EarliPoint SystemEarlitec Diagnostics · 510(k) 2025
- NeuroraArgus Cognitive, Inc. · 510(k) 2026
- EarliPoint AssessmentEarlitec Diagnostics · 510(k) 2026
- Canvas DxCognoa, Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.